Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor–Positive Metastatic Breast Cancer-Reference-Cited by-同舟云学术

Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor–Positive Metastatic Breast Cancer

Published:2016-06-07 Issue:24 Volume:22 Page:6002-6009
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Li Weimin,O'Shaughnessy Joyce,Hayes Daniel,Campone Mario,Bondarenko Igor,Zbarskaya Irina,Brain Etienne,Stenina Marina,Ivanova Olga,Graas Marie-Pascale,Neven Patrick,Ricci Deborah,Griffin Thomas,Kheoh Thian,Yu Margaret,Gormley Michael,Martin Jason,Schaffer Michael,Zelinsky Kathy,De Porre Peter,Johnston Stephen R.D.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of androgen receptor and tumour-infiltrating lymphocytes with bone recurrence in triple-negative breast cancer;Journal of Bone Oncology;2024-02

2. Determination of the androgen receptor status of disseminated tumor cells in primary breast cancer patients;Archives of Gynecology and Obstetrics;2023-10-30

3. Determination of the Androgen Receptor Status of Disseminated Tumor Cells in Primary Breast Cancer Patients;2023-05-31

4. Androgen Receptor Is Expressed in the Majority of Breast Cancer Brain Metastases and Is Subtype-Dependent;Cancers;2023-05-13

5. Enzalutamide and EPI-001 in T47D: Blocking Androgen receptor/Androgen receptor variant7 modulates NF-ĸB/c-Myc axis, cyclins A, E, & C, epithelial to mesenchymal transition markers, angiogenesis, and metastasis;2023-01-05